Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 9,487 | 786 | 1,455 | 1,135 | 855 |
| Gross Profit | 9,487 | 786 | 1,455 | 1,135 | 855 |
| Operating Expenses | 8,721 | 6,458 | 8,089 | 7,362 | 7,147 |
| Operating Income | 766 | -5,672 | -6,634 | -6,227 | -6,292 |
| Other Income | -31,657 | -5,195 | -2,224 | 5,556 | -341 |
| Pre-tax Income | -30,891 | -10,867 | -8,858 | -671 | -6,633 |
| Net Income Continuous | -30,891 | -10,867 | -8,858 | -671 | -6,633 |
| Minority Interests | -13 | -14 | -14 | -13 | -10 |
| Net Income | $-30,877 | $-10,853 | $-8,844 | $-659 | $-6,622 |
| EPS Basic Total Ops | -7.68 | -2.88 | -2.88 | -0.24 | -2.40 |
| EPS Basic Continuous Ops | -7.73 | -2.90 | -2.72 | -0.17 | -2.35 |
| EPS Diluted Total Ops | -7.68 | -2.88 | -2.88 | -0.24 | -2.40 |
| EPS Diluted Continuous Ops | -7.73 | -2.90 | -2.72 | -0.17 | -2.35 |
| EBITDA(a) | $1,249 | $-5,186 | $-6,146 | $-5,727 | $-5,792 |